ATE439867T1 - Konjugate zur intrazellularen bildgebung sowie zur unterscheidung zwischen tumor und nicht- tumorzellen - Google Patents

Konjugate zur intrazellularen bildgebung sowie zur unterscheidung zwischen tumor und nicht- tumorzellen

Info

Publication number
ATE439867T1
ATE439867T1 AT03731697T AT03731697T ATE439867T1 AT E439867 T1 ATE439867 T1 AT E439867T1 AT 03731697 T AT03731697 T AT 03731697T AT 03731697 T AT03731697 T AT 03731697T AT E439867 T1 ATE439867 T1 AT E439867T1
Authority
AT
Austria
Prior art keywords
tumor
conjugates
differentiation
tumor cells
intracellular imaging
Prior art date
Application number
AT03731697T
Other languages
English (en)
Inventor
Klaus Braun
Jurgen Debus
Jurgen Jenne
Stefan Heckl
Rudiger Pipkorn
Ralf Rastert
Waldemar Waldeck
Isabell Braun
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE439867T1 publication Critical patent/ATE439867T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03731697T 2002-01-22 2003-01-22 Konjugate zur intrazellularen bildgebung sowie zur unterscheidung zwischen tumor und nicht- tumorzellen ATE439867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20020001506 EP1329227A1 (de) 2002-01-22 2002-01-22 Konjugat zur intrazellulären Bildgebung sowie zur Unterscheidung von Tumor- und nicht-Tumorzellen
PCT/EP2003/000609 WO2003061712A1 (en) 2002-01-22 2003-01-22 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells

Publications (1)

Publication Number Publication Date
ATE439867T1 true ATE439867T1 (de) 2009-09-15

Family

ID=8185325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03731697T ATE439867T1 (de) 2002-01-22 2003-01-22 Konjugate zur intrazellularen bildgebung sowie zur unterscheidung zwischen tumor und nicht- tumorzellen

Country Status (5)

Country Link
US (1) US7531502B2 (de)
EP (2) EP1329227A1 (de)
AT (1) ATE439867T1 (de)
DE (1) DE60328864D1 (de)
WO (1) WO2003061712A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
EP1329227A1 (de) 2002-01-22 2003-07-23 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur intrazellulären Bildgebung sowie zur Unterscheidung von Tumor- und nicht-Tumorzellen
EP1424343A1 (de) * 2002-11-29 2004-06-02 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Peptidkonjugat zur molekularen Zellkernabbildung oder Tumorbehandlung
WO2006056227A1 (en) * 2004-11-27 2006-06-01 Eberhard-Karls- Universität Tübingen Universitätsklinikum Conjugates comprising the active agent and flanking or branched-chain peptides
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102008043654A1 (de) * 2008-11-11 2010-05-20 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Diagnostisches und/oder therapeutisches Agens, Verfahren zu seiner Herstellung und Verwendung
CN102361647B (zh) 2009-01-23 2018-02-16 诺沃-诺迪斯克有限公司 具有白蛋白结合剂a‑b‑c‑d‑e‑的fgf21衍生物及其应用
WO2011154349A2 (en) 2010-06-08 2011-12-15 Novo Nordisk A/S Fgf21 analogues and derivatives
CN103415300B (zh) 2010-07-20 2018-02-23 诺沃—诺迪斯克有限公司 N‑末端修饰的fgf21化合物
JP6411218B2 (ja) 2012-02-15 2018-10-24 ノヴォ ノルディスク アー／エス 骨髄細胞で発現されるトリガー受容体１（ｔｒｅｍ−１）に結合し、それを遮断する抗体
CN104203977A (zh) 2012-02-15 2014-12-10 诺和诺德A/S（股份有限公司） 结合肽聚糖识别蛋白1的抗体
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
EA037844B1 (ru) 2014-07-17 2021-05-27 Ново Нордиск А/С Сайт-направленный мутагенез антител к trem-1
AR103246A1 (es) 2014-12-23 2017-04-26 Novo Nordiks As Derivados de fgf21 y sus usos
CN106317226B (zh) 2016-08-19 2017-09-05 安源医药科技（上海）有限公司 用于构建融合蛋白的连接肽
CN106279437B (zh) 2016-08-19 2017-10-31 安源医药科技（上海）有限公司 高糖基化人凝血因子viii融合蛋白及其制备方法与用途
US11123438B2 (en) 2016-08-19 2021-09-21 Ampsource Biopharma Shanghai Inc. Linker peptide for constructing fusion protein
WO2019195126A1 (en) 2018-04-02 2019-10-10 Bristol-Myers Squibb Company Anti-trem-1 antibodies and uses thereof
US11981718B2 (en) 2020-05-27 2024-05-14 Ampsource Biopharma Shanghai Inc. Dual-function protein for lipid and blood glucose regulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19933492B4 (de) * 1999-07-16 2008-01-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung
US20060074034A1 (en) * 2001-09-17 2006-04-06 Collins Douglas A Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
EP1329227A1 (de) 2002-01-22 2003-07-23 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur intrazellulären Bildgebung sowie zur Unterscheidung von Tumor- und nicht-Tumorzellen

Also Published As

Publication number Publication date
EP1329227A1 (de) 2003-07-23
DE60328864D1 (de) 2009-10-01
US7531502B2 (en) 2009-05-12
EP1467772A1 (de) 2004-10-20
EP1467772B1 (de) 2009-08-19
WO2003061712A1 (en) 2003-07-31
US20060019249A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
ATE439867T1 (de) Konjugate zur intrazellularen bildgebung sowie zur unterscheidung zwischen tumor und nicht- tumorzellen
EP2260942A3 (de) Probenahmesystem mit proteasehemmer
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
ATE527552T1 (de) Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe
EP2298301A3 (de) Medikamente zur Erhöhung yon endogenem Erythropoietin (EPO)
WO2002024956A3 (en) Genetic markers for tumors
IS6455A (is) Stöðvun á vexti taugasíma fyrir milligöngu viðtaka Nogo
MXPA02003027A (es) Metodo para proveer servicios de diagnostico clinico.
EP1404860A4 (de) Zuführsystem für nukleinsäuren
MA28153A1 (fr) Acides nucléiques se liant spécifiquement à la ghréline biologiquement active
EP2251695A3 (de) Mit endometrialer krankheit assoziierte marker
EP1341414A4 (de) Marines actinomyceten-taxon für die wirkstoff-forschung
CY1106682T1 (el) Ενωση λακταμης
EP1706128A4 (de) Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
EP1543331A4 (de) Verfahren zur diagnose von morbus alzheimer
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
SG149685A1 (en) Polymer conjugates of neublastin and methods of using same
WO2004006854A3 (en) Method for identification of biologically active agents
ATE310802T1 (de) Gewebe-array-instrument
IT1317070B1 (it) Pilastro di guarigione per immobilizzazione intrachirurgica diimpianti dentali per carico immediato.
WO2004113574A3 (en) Methods for disease screening
DE59915208D1 (de) Mahlhilfsmittel für die Röntgenfluoreszenzanalyse
ATA87398A (de) Stellvorrichtung für einen luftantrieb, insbesondere für ein medizinisches bzw. dentales instrument

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties